Could an Anti-Inflammatory diet ease lupus pain and fatigue?
NCT ID NCT07713940
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study investigates whether a 6-week anti-inflammatory diet can improve pain and fatigue in people with systemic lupus erythematosus (SLE). Participants follow a specially designed diet while researchers track changes in patient-reported outcomes like pain interference and fatigue. The goal is to see if dietary changes can help manage lupus symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an anti-inflammatory diet
- What this could lead to
- If it works, this could point toward a simple dietary approach to help manage lupus symptoms like pain and fatigue.
- What could go wrong
- This is a small, early-stage trial with only 36 participants and no control group, so results may not be conclusive or widely applicable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Altman Clinical Translational Research Insitute (UC San Diego)
RECRUITINGLa Jolla, California, 92097, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood marker may reveal hidden heart risks in lupus
- Engineered immune cells aim to tame autoimmune diseases
- New drug MTM-H-001 targets B-Cell autoimmune diseases in early trial
- Engineered immune cells take on lupus and other autoimmune diseases
- New antibody aims to tame lupus by targeting troublemaking cells
- Immune cells engineered to fight lupus enter first human tests